These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2371300)

  • 21. An industrial and UK perspective on short-term testing.
    Gatehouse DG
    Prog Clin Biol Res; 1990; 340D():249-59. PubMed ID: 2371298
    [No Abstract]   [Full Text] [Related]  

  • 22. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Historical review of the rodent bioassay and future directions.
    McConnell EE
    Regul Toxicol Pharmacol; 1995 Feb; 21(1):38-43; discussion 81-6. PubMed ID: 7784634
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk assessment: the default conservatism controversy.
    Barnard RC
    Regul Toxicol Pharmacol; 1995 Jun; 21(3):431-8. PubMed ID: 7480897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal studies in potency ranking of carcinogens in Norway.
    Sanner T; Dybing E; Hardeng S; Haug E; Ovrebø S
    Prog Clin Biol Res; 1992; 374():399-414. PubMed ID: 1620715
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes.
    Cimino MC
    Environ Mol Mutagen; 2006 Jun; 47(5):362-90. PubMed ID: 16649190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. US environmental-cancer guidelines proposed.
    Firshein J
    Lancet; 1996 Apr; 347(9009):1179. PubMed ID: 8609770
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
    Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutagenicity of natural-origin agents carcinogenic to humans].
    Nersesian AK
    Eksp Onkol; 1990; 12(1):3-6. PubMed ID: 2404738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precedents or possibilities: which should guide the harmonization of mutagenicity test protocols and carcinogen prediction strategies?
    Ashby J
    Mutat Res; 1993 Feb; 298(4):291-5. PubMed ID: 7678166
    [No Abstract]   [Full Text] [Related]  

  • 32. Developmental status of bioassays in genetic toxicology. A report of Phase II of the U.S. Environmental Protection Agency Gene-Tox Program.
    Brusick D; Auletta A
    Mutat Res; 1985; 153(1-2):1-10. PubMed ID: 3974625
    [No Abstract]   [Full Text] [Related]  

  • 33. Testing for carcinogens: shift from animals to automation gathers steam--slowly.
    Schmidt C
    J Natl Cancer Inst; 2009 Jul; 101(13):910-2. PubMed ID: 19549960
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction of mutagenicity, carcinogenicity, developmental toxicity, and skin sensitisation with Caesar program for a set of conazoles.
    Bolčič-Tavčar M; Vračko M
    Arh Hig Rada Toksikol; 2012 Sep; 63(3):283-92. PubMed ID: 23152378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of the Gene-Tox Program.
    Auletta AE; Brown M; Wassom JS; Cimino MC
    Environ Health Perspect; 1991 Dec; 96():33-6. PubMed ID: 1820273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of current efforts in short-term carcinogen testing.
    Milman HA; Hurley PM; Auletta A
    Environ Health Perspect; 1983 Apr; 50():355-7. PubMed ID: 6873027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies.
    Ellinger-Ziegelbauer H; Gmuender H; Bandenburg A; Ahr HJ
    Mutat Res; 2008 Jan; 637(1-2):23-39. PubMed ID: 17689568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational approach to the quantification of genotoxicity.
    Benigni R
    Environ Mol Mutagen; 1992; 19(1):83-9. PubMed ID: 1732108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophilicity of nongenotoxic carcinogens and genotoxic noncarcinogens as measured by the ke test.
    Bakale G; McCreary RD
    Prog Clin Biol Res; 1990; 340D():355-65. PubMed ID: 2371305
    [No Abstract]   [Full Text] [Related]  

  • 40. [Problems in the study of mutagenic effects of environmental factors (review)].
    Mozhaeva TE
    Gig Sanit; 1996; (5):38-40. PubMed ID: 8974934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.